Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Inflammatory Synaptopathy as a Target of Exercise Therapy in the Fight Against Multiple Sclerosis

NCT03735524 is registered in ClinicalTrials.gov with Neuromed IRCCS as lead sponsor.

NCT NCT03735524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03735524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Inflammatory Synaptopathy as a Target of Exercise Therapy in the Fight Against Multiple Sclerosis
Lead sponsor
Neuromed IRCCS
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2019
Completion date
May 31, 2021
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis